Cost Of Revenue - UBCare Co Ltd (KOSDAQ:032620) - Alpha Spread
U

UBCare Co Ltd
KOSDAQ:032620

Watchlist Manager
UBCare Co Ltd
KOSDAQ:032620
Watchlist
Price: 3 980 KRW 0.51% Market Closed
Market Cap: 202.6B KRW
Have any thoughts about
UBCare Co Ltd?
Write Note

UBCare Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

UBCare Co Ltd
Cost of Revenue Peer Comparison

Comparables:
D
315640
e
099750
C
311690
L
328130
J
322510

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
U
UBCare Co Ltd
KOSDAQ:032620
Cost of Revenue
-â‚©84.2B
CAGR 3-Years
-19%
CAGR 5-Years
-9%
CAGR 10-Years
-11%
D
DeepNoid Inc
KOSDAQ:315640
Cost of Revenue
-â‚©1.1B
CAGR 3-Years
-29%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
e
ezCaretech Co Ltd
KOSDAQ:099750
Cost of Revenue
-â‚©62.9B
CAGR 3-Years
-5%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
C
CJ Bioscience Inc
KOSDAQ:311690
Cost of Revenue
-â‚©3.7B
CAGR 3-Years
-9%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
L
Lunit Inc
KOSDAQ:328130
Cost of Revenue
-â‚©113.2m
CAGR 3-Years
-26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
JLK Inc
KOSDAQ:322510
Cost of Revenue
-â‚©5.6B
CAGR 3-Years
5%
CAGR 5-Years
-142%
CAGR 10-Years
N/A

See Also

What is UBCare Co Ltd's Cost of Revenue?
Cost of Revenue
-84.2B KRW

Based on the financial report for Jun 30, 2024, UBCare Co Ltd's Cost of Revenue amounts to -84.2B KRW.

What is UBCare Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-11%

Over the last year, the Cost of Revenue growth was -18%. The average annual Cost of Revenue growth rates for UBCare Co Ltd have been -19% over the past three years , -9% over the past five years , and -11% over the past ten years .

Back to Top